CANLab Partners with cliexa庐 for Multidimensional Pain Tracking Research
cliexa庐 Partners with the University of 欧美口爆视频 Boulder's Cognitive and Affective Neuroscience Lab (CANLab) for Multidimensional Pain Tracking and Predictive Analytics Research.
cliexa, Inc., which offers a suite of mobile platforms for chronic disease management, announces its collaboration with 欧美口爆视频 Boulder鈥檚 CANLab and Institute of Cognitive Science (ICS). cliexa will collaborate with CANLab鈥檚 team, headed by Professor Tor Wager, as they lead in multidimensional pain tracking and predictive analytics research.
欧美口爆视频 Boulder jointly filed a provisional patent with cliexa for the multidimensional objective pain concept with CANLab. The CANLab focuses on identifying a particular pattern of brain activity, which is diagnostic of physical pain.聽cliexa-Ease鈥檚 mobile platform hosts the research concept and is being used to further develop CANLab鈥檚 existing pain studies. cliexa-Ease will deliver an exclusive pain assessment model, which, in collaboration with 欧美口爆视频 Boulder, anticipates commercialization by mid 2018.
Mehmet Kazgan, founder and CEO of cliexa, explains how they are excited about the partnership with Wager鈥檚 CANLab because of its 鈥渓eading research studies for multidimensional pain tracking.鈥 He also describes how 鈥渨orking with neuroscientists at University of 欧美口爆视频 Boulder is taking [the cliexa platform] to the next level of objectifying patient outputs with multiple reference points.鈥
Professor Wager highlights how the collaboration will 鈥渆xpand our ability to understand how emotion affects pain in daily life.鈥 Dr. Pavel Goldstein, the scientific lead of the project,聽adds the partnership will provide both 鈥渁n incredible opportunity to establish a聽platform for researching chronic pain conditions鈥 and 鈥渋mportant feedback to pain patients and their clinicians with unique information about patient health.鈥
欧美口爆视频 Cognitive and Affective Neuroscience Lab
Professor Tor Wager leads CANLab, which is housed by 欧美口爆视频 Boulder鈥檚 Institute of Cognitive Science (ICS) and the Psychology and Neuroscience Department. CANLab uses聽machine-learning to develop fMRI-based biomarkers for clinically relevant outcomes, such as pain. It subsequently tests how psychological factors influence these biomarkers. The lab also engages in collaborative, translational research, which incorporates brain systems-level analyses into the study of clinical disorders, including PTSD, depression, schizophrenia, and chronic pain.聽
Learn more about the CANLab at聽
欧美口爆视频 cliexa
The mobile platform technology developed by cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and medication adherence through patient reported outcomes through real-time integration to electronic medical records, which streamline processes and increase efficiency in population health management.
Learn more about cliexa at